Last edition
News about "Suven Pharmaceuticals"
Suven Pharmaceuticals Secures NCLT Approval for Merger with Cohance Lifesciences
Over 99.9994 percent of Suven’s equity shareholders and 99.967 percent of Cohance’s shareholders voted in favor of the Scheme of Amalgamation during meetings held on November 28, 2024.
Suven Pharmaceuticals | 31/03/2025 | By Aishwarya
Suven Pharma to Acquire Stake in NJ Bio with Investment of USD 64.4 Million
NJ Bio has served 150+ customers, delivered over 500 projects in 5 years, and won the prestigious World ADC Awards for four consecutive years.
Suven Pharmaceuticals | 09/12/2024 | By Aishwarya
Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive Chairman
Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO business (2020-22).
Suven Pharmaceuticals | 21/09/2024 | By Aishwarya | 262
Suven to Acquire Majority Stake in Sapala Organics
Suven Pharmaceuticals has signed a definitive agreement for a strategic controlling investment in Sapala Organics Private Ltd.
Suven Pharmaceuticals | 14/06/2024 | By Aishwarya | 222
US FDA issues EIR to Suven Pharma's subsidiary
The pre-approval inspection was conducted between July 25 to July 29, 2022
Suven Pharmaceuticals | 04/10/2022 | By Sudeep Soparkar | 574
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy